Diabetes and sarcopenia are emerging as serious public health issues. Sarcopenia, an age-
related disorder characterized by loss of skeletal muscle mass and function, is recognized …

The life expectancy of the population is increasing worldwide due to improvements in the
prevention, diagnosis, and treatment of diseases. This favors a higher prevalence of type 2 …

DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM)
and is based on promoting the incretin effect. Here, the authors have presented a brief …

Sarcopenia, characterized by loss of skeletal muscle mass, quality, and strength, has
become a common hallmark of ageing and many chronic diseases. Diabetes mellitus …

Aims Sarcopenia generally refers to the age-related reduction in muscle strength, functional
ability, and muscle mass. Sarcopenia is a multifactorial condition associated with poor …

Although the lifespan of people with diabetes has increased in many countries, the age‐
related increase in comorbidities (sarcopenia, frailty and disabilities) and diabetic …

Sarcopenia is an age-related clinical complaint characterized by the progressive
deterioration of skeletal muscle mass and strength over time. Type 2 diabetes (T2D) is …

Sarcopenia, the age-related loss of muscle strength and mass or quality, is a common
condition with major adverse consequences. Although the pathophysiology is incompletely …

Type 2 diabetes mellitus (T2DM) and sarcopenia (low skeletal muscle mass and function)
share a bidirectional relationship. The prevalence of these diseases increases with age and …

ABSTRACT Aims/Introduction Diabetes and sarcopenia have a two‐way relationship with
each other with advanced age. Additionally, malnutrition is correlated with a higher risk of …